These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7945784)

  • 21. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
    Smith AJ; Gordon TP; Macardle PJ
    Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
    Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
    Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human killer inhibitory receptors: specificity for HLA-class I molecules and mechanisms of signal transduction.
    Colonna M; Döhring C; Samaridis J; Scheidegger D; Dessing M; Cella M; Campbell KS
    Transplant Proc; 1996 Dec; 28(6):3035. PubMed ID: 8962177
    [No Abstract]   [Full Text] [Related]  

  • 25. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
    Chaouchi N; Vazquez A; Galanaud P; Leprince C
    J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of CD22 with the B cell antigen receptor.
    Peaker CJ; Neuberger MS
    Eur J Immunol; 1993 Jun; 23(6):1358-63. PubMed ID: 7684686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive endocytosis and degradation of CD22 by human B cells.
    Shan D; Press OW
    J Immunol; 1995 May; 154(9):4466-75. PubMed ID: 7722303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
    Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
    Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.
    Schwartz-Albiez R; Dörken B; Monner DA; Moldenhauer G
    Int Immunol; 1991 Jul; 3(7):623-33. PubMed ID: 1716973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.
    Lajaunias F; Nitschke L; Moll T; Martinez-Soria E; Semac I; Chicheportiche Y; Parkhouse RM; Izui S
    J Immunol; 2002 Jun; 168(12):6078-83. PubMed ID: 12055217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-receptors of B lymphocytes.
    O'Rourke L; Tooze R; Fearon DT
    Curr Opin Immunol; 1997 Jun; 9(3):324-9. PubMed ID: 9203413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class II signaling in B-cell activation.
    Scholl PR; Geha RS
    Immunol Today; 1994 Sep; 15(9):418-22. PubMed ID: 7524519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
    Cornall RJ; Goodnow CC; Cyster JG
    Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperresponsive B cells in CD22-deficient mice.
    O'Keefe TL; Williams GT; Davies SL; Neuberger MS
    Science; 1996 Nov; 274(5288):798-801. PubMed ID: 8864124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD20: a regulator of cell-cycle progression of B lymphocytes.
    Tedder TF; Engel P
    Immunol Today; 1994 Sep; 15(9):450-4. PubMed ID: 7524522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.
    Sato S; Miller AS; Inaoki M; Bock CB; Jansen PJ; Tang ML; Tedder TF
    Immunity; 1996 Dec; 5(6):551-62. PubMed ID: 8986715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.
    Doody GM; Justement LB; Delibrias CC; Matthews RJ; Lin J; Thomas ML; Fearon DT
    Science; 1995 Jul; 269(5221):242-4. PubMed ID: 7618087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The B-cell adhesion molecule CD22 is cross-species reactive and recognizes distinct sialoglycoproteins on different functional T-cell sub-populations.
    Sgroi D; Stamenkovic I
    Scand J Immunol; 1994 May; 39(5):433-8. PubMed ID: 8191218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.